The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Recordati Rare Diseases Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
33 result(s) found, displaying 11 to 20
-
Prescription medicine registrationActive ingredients: mercaptamine (cysteamine).
-
QARZIBA dinutuximab beta 4.5 mg/mL concentrate for solution for infusion, 20 mg/4.5 mL vial (321016)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for QARZIBA dinutuximab beta 4.5 mg/mL concentrate for solution for infusion, 20 mg/4.5 mL vial. -
-
Designation or determinationOrphan drug
-
Prescription medicine registrationActive ingredients: chlormethine hydrochloride.
-
Designation or determinationOrphan drug
-
Designation or determinationOrphan drug
-
Designation or determinationOrphan drug
-
Designation or determinationOrphan drug
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PEDEA ibuprofen 10 mg/2 mL solution for intravenous infusion 2 mL glass ampoule.